Borer Denton & Associates Inc. Sells 21,701 Shares of CVS Health Co. (NYSE:CVS)

Borer Denton & Associates Inc. trimmed its position in CVS Health Co. (NYSE:CVS - Free Report) by 30.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 49,010 shares of the pharmacy operator's stock after selling 21,701 shares during the quarter. CVS Health makes up 1.1% of Borer Denton & Associates Inc.'s holdings, making the stock its 27th largest position. Borer Denton & Associates Inc.'s holdings in CVS Health were worth $3,082,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of CVS. MidAtlantic Capital Management Inc. bought a new position in shares of CVS Health during the third quarter worth approximately $25,000. Livelsberger Financial Advisory bought a new position in CVS Health during the 3rd quarter worth $31,000. Reston Wealth Management LLC acquired a new position in CVS Health in the 3rd quarter valued at $32,000. First Community Trust NA grew its holdings in shares of CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator's stock worth $33,000 after purchasing an additional 302 shares in the last quarter. Finally, Kathleen S. Wright Associates Inc. acquired a new position in CVS Health in the third quarter valued at about $33,000. Institutional investors own 80.66% of the company's stock.

CVS Health Stock Performance

Shares of NYSE CVS traded up $0.91 during mid-day trading on Friday, reaching $58.01. 11,153,900 shares of the company's stock were exchanged, compared to its average volume of 12,620,673. The firm has a market capitalization of $73.00 billion, a price-to-earnings ratio of 14.72, a price-to-earnings-growth ratio of 0.96 and a beta of 0.55. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. CVS Health Co. has a 52 week low of $52.71 and a 52 week high of $83.25. The firm has a 50-day moving average price of $59.21 and a two-hundred day moving average price of $58.63.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. During the same period in the prior year, the firm earned $2.21 earnings per share. The company's revenue was up 6.3% compared to the same quarter last year. Analysts predict that CVS Health Co. will post 5.43 EPS for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.59%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health's payout ratio is presently 67.51%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on CVS shares. Wells Fargo & Company raised shares of CVS Health from an "equal weight" rating to an "overweight" rating and raised their target price for the company from $60.00 to $66.00 in a report on Monday, November 18th. Deutsche Bank Aktiengesellschaft dropped their price target on CVS Health from $64.00 to $63.00 and set a "hold" rating for the company in a research note on Friday, August 9th. Royal Bank of Canada reduced their target price on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a report on Friday, November 15th. Mizuho decreased their price target on CVS Health from $73.00 to $66.00 and set an "outperform" rating for the company in a report on Thursday, October 24th. Finally, TD Cowen upgraded shares of CVS Health from a "hold" rating to a "buy" rating and boosted their target price for the company from $59.00 to $85.00 in a research report on Friday, October 4th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, CVS Health has an average rating of "Moderate Buy" and a consensus target price of $72.28.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.